AXGN · Nasdaq · CIK 0000805928
Axogen, Inc.
Axogen, Inc.’s most recent SEC filing in our snapshot is a Form SCHEDULE 13G filed on Oct 2, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $225.2M and net income of -$15.7M, according to its XBRL data on EDGAR. Its EDGAR record lists 52 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Axogen, Inc.
- Ticker
- AXGN
- SEC Central Index Key (CIK)
- 0000805928
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus (code 3845)
- Business address
- ALACHUA, FL
- State or country of incorporation
- MN
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #1925 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Axogen, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $127.4M | $138.6M | $159.0M | $187.3M | $225.2M |
| Net income | -$27.0M | -$28.9M | -$21.7M | -$10.0M | -$15.7M |
| Diluted EPS | -$0.65 | -$0.69 | -$0.51 | -$0.23 | -$0.34 |
| Total assets | $208.0M | $195.4M | $196.8M | $203.7M | $221.7M |
| Cash and equivalents | $32.8M | $15.3M | $31.0M | $27.6M | $35.5M |
XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Feb 24, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Jul 29, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Oct 1, 2026 | 8-K | Regulation FD disclosure· period Oct 1, 2026 | Document · Index |
| Apr 29, 2026 | DEF 14A | AXGN DEFINITIVE PROXY STATEMENT· period Dec 31, 2025 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about Axogen, Inc., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 2, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Oct 1, 2026 | 8-K | Regulation FD disclosure· period Oct 1, 2026 | Document · Index |
| Sep 10, 2026 | 424B5 | 424B5 | Document · Index |
| Sep 10, 2026 | 8-K/A | Material agreement; Regulation FD disclosure· period Sep 9, 2026 | Document · Index |
| Sep 10, 2026 | 8-K | Material agreement; Regulation FD disclosure; Other events· period Sep 9, 2026 | Document · Index |
| Sep 4, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 2, 2026 | Document · Index |
| Sep 2, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 14, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 10, 2026 | Document · Index |
| Aug 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 11, 2026 | Document · Index |
| Aug 11, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 7, 2026 | Document · Index |
| Aug 10, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 7, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jul 31, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Jul 29, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Jul 29, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Jul 29, 2026 | Document · Index |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 24, 2026 | Document · Index |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 24, 2026 | Document · Index |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 24, 2026 | Document · Index |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 24, 2026 | Document · Index |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 24, 2026 | Document · Index |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 24, 2026 | Document · Index |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 24, 2026 | Document · Index |
| Jun 23, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 19, 2026 | Document · Index |
| Jun 23, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 19, 2026 | Document · Index |
| Jun 23, 2026 | 8-K | Shareholder vote results· period Jun 23, 2026 | Document · Index |
| Jun 23, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 19, 2026 | Document · Index |
| Jun 23, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 19, 2026 | Document · Index |
| Jun 23, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 19, 2026 | Document · Index |
| Jun 23, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 19, 2026 | Document · Index |
| Jun 23, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 19, 2026 | Document · Index |
| May 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 8, 2026 | Document · Index |
| May 8, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| May 8, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 8, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 8, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 8, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 8, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 7, 2026 | Document · Index |
| May 8, 2026 | 3 | Initial statement of beneficial ownership· period May 1, 2026 | Document · Index |
Insider filing activity
52 Form 4 filings appear in Axogen, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Electromedical & Electrotherapeutic Apparatus
- MDT Medtronic plc
- LIVN LivaNova PLC
- ITGR Integer Holdings Corp
- TMDX TransMedics Group, Inc.
- CNMD CONMED Corp
- CBLL Ceribell, Inc.
- INMD InMode Ltd.
All 8 companies in Electromedical & Electrotherapeutic Apparatus· Companies headquartered in Florida
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000805928 and XBRL company facts. Axogen, Inc. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement